Differentiating atrial tachycardias with centrifugal activation: Lessons from high-resolution mapping.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
07 2021
Historique:
received: 12 12 2020
revised: 22 03 2021
accepted: 23 03 2021
pubmed: 2 4 2021
medline: 11 2 2022
entrez: 1 4 2021
Statut: ppublish

Résumé

Centrifugal activation is not always the origin of a focal atrial tachycardia (AT) ("true-focal"), but passive activation from the other structures ("pseudo-focal"). We aimed to establish a method to differentiate true-focal from pseudo-focal. In 49 centrifugal activations in 35 patients with AT, 12-lead electrocardiogram, activation map, atrial global activation histogram (GAH), and local electrograms were analyzed. GAH demonstrates the relation between the activation area and timing through the cycle length, displayed with a normalized value, ranging from 0 (smallest activation area) to 1.0 (largest activation area). Of 30 centrifugal activations observed in the septal region, 6/30 (20.0%) were true-focal. The remaining 24/60 (80.0%) were pseudo-focal, of which 23 (95.8%) were from the opposite chamber. P-wave/flutter-wave duration < 200 ms discriminated true-focal from pseudo-focal (sensitivity 100%; specificity 54.5%; positive predictive value 33.3%; negative predictive value 100%). Multiple breakthrough ruled out the possibility of a true-focal AT. Other differentiating factors were an activation area within the initial 20 ms of <5 mm Centrifugal activation is not necessarily due to a focal AT but passive activation. The activation map with GAH in addition to the 12-lead electrocardiogram and local electrograms enables an accurate differentiation.

Sections du résumé

BACKGROUND
Centrifugal activation is not always the origin of a focal atrial tachycardia (AT) ("true-focal"), but passive activation from the other structures ("pseudo-focal").
OBJECTIVE
We aimed to establish a method to differentiate true-focal from pseudo-focal.
METHODS
In 49 centrifugal activations in 35 patients with AT, 12-lead electrocardiogram, activation map, atrial global activation histogram (GAH), and local electrograms were analyzed. GAH demonstrates the relation between the activation area and timing through the cycle length, displayed with a normalized value, ranging from 0 (smallest activation area) to 1.0 (largest activation area).
RESULTS
Of 30 centrifugal activations observed in the septal region, 6/30 (20.0%) were true-focal. The remaining 24/60 (80.0%) were pseudo-focal, of which 23 (95.8%) were from the opposite chamber. P-wave/flutter-wave duration < 200 ms discriminated true-focal from pseudo-focal (sensitivity 100%; specificity 54.5%; positive predictive value 33.3%; negative predictive value 100%). Multiple breakthrough ruled out the possibility of a true-focal AT. Other differentiating factors were an activation area within the initial 20 ms of <5 mm
CONCLUSION
Centrifugal activation is not necessarily due to a focal AT but passive activation. The activation map with GAH in addition to the 12-lead electrocardiogram and local electrograms enables an accurate differentiation.

Identifiants

pubmed: 33794392
pii: S1547-5271(21)00309-X
doi: 10.1016/j.hrthm.2021.03.038
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1122-1131

Informations de copyright

Copyright © 2021 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Masateru Takigawa (M)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France; Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: teru.takigawa@gmail.com.

Takamitsu Takagi (T)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France; Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Claire A Martin (CA)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France; Royal Papworth Hospital, Cambridge, United Kingdom.

Nicolas Derval (N)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Arnaud Denis (A)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Konstantinos Vlachos (K)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Ghassen Cheniti (G)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Josselin Duchateau (J)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Thomas Pambrun (T)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Yasuhiro Shirai (Y)

Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Susumu Tao (S)

Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Yoshihide Takahashi (Y)

Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Masahiko Goya (M)

Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Frederic Sacher (F)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Hubert Cochet (H)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Meleze Hocini (M)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Michel Haissaguerre (M)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Tetsuo Sasano (T)

Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Pierre Jais (P)

Lyric Institute, CHU Bordeaux, Université de Bordeaux, Bordeaux-Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH